Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 214264
Company: ZYDUS PHARMS
Company: ZYDUS PHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
TOFACITINIB | TOFACITINIB CITRATE | EQ 11MG BASE | TABLET, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
TOFACITINIB | TOFACITINIB CITRATE | EQ 22MG BASE | TABLET, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
08/19/2021 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/214264Orig1s000ltr.pdf |